Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now

You can switch off notifications anytime using browser settings.
Stock Analysis, IPO, Mutual Funds, Bonds & More
Zydus Cadila gets final nod from USFDA to market generic seizures drug

Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Lamotrigine extended-release tablets USP in the strengths of 25 mg, 50 mg, 100 mg, 200 mg, 250 mg, and 300 mg, Zydus Cadila said in a statement.

Implementation date for track, trace system for exports of drug formulations extended

"The date for implementation of track and trace system for export of drug formulations with respect to maintaining the parent-child relationship in packaging levels and its uploading on central portal has been extended upto October 1 this year for both SSI and non-SSI manufactured drugs," DGFT has said in a public notice.

Covid-19 vaccine: A race against time

With vaccines being the need of the hour to combat the Covid-19 virus, a number of companies have come forward to develop potential candidates. Faced with surging infections every day around the globe, some companies are repurposing existing drugs to fast-track a cure. Divya Rajagopal brings you an update on corporates, governments and drug companies which are currently in a race against time to develop a vaccine.

Can 'Ars Alb-30' protect you from Covid-19? AYUSH Ministry thinks so

Panic-stricken citizens are flocking to homoeopathy doctors for consultation, and also to get prescriptions for arcenium album. Manufacturers of this compound – derived from the metallic element arsenic – have been dealing with “three-times bigger orders” since the AYUSH (Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha & Homoeopathy) directive.

Aurobindo, Sandoz call off USD 900 mn deal

The transaction if completed would have positioned the Hyderabad-based firm as the second largest dermatology player and the second largest generics company in the US by prescriptions.

Novartis scraps sale of assets including COVID-19 hopeful to India's Aurobindo

Novartis AG on Thursday scrapped the $1 billion sale of U.S. generic pill and skin drug assets to India's Aurobindo Pharma Ltd as regulators balked, setting back the Swiss drugmaker's shift to more profitable medicines.

Two Mumbai companies step up work on COVID-19 drug helping in recovery

Mumbai-based BDR Pharma, which makes anti-HIV and Hepatitis C medication, and LASA Supergenerics, an active pharmaceutical ingredient maker, are betting that the drug works. While BDR has started lab work to get the initial samples out, it has several hurdles to cross before the product hits the market, the biggest being getting the actual reference product shipped from China.

COVID-19: India likely to ease some drug export curbs after U.S. pressure soon, says sources

India will likely relax some export restrictions on pharmaceutical products soon due to intense pressure from the United States which is worried about drug shortages as the number of coronavirus cases surge.

Medical devices to be regulated as drugs for quality control, price monitoring: Government

The manufacturer and importer shall also be liable to deposit the overcharged amount along with interest thereon from the date of increase in price in addition to penalty, it added.

Torrent Group commits Rs 100 cr to fight COVID-19 pandemic

The Ahmedabad-headquartered company said it would contribute Rs 50 crore to the PM – CARES Fund and additional Rs 50 cr under various other initiatives concerning the pandemic.

A coronavirus vaccine in 18 months? Experts urge reality check

Most vaccines go through years of tests before they hit the market; 12 to 18 months would be extraordinarily fast. The coronavirus shots moving most rapidly are made with brand-new technologies that have never proven useful in humans.

Covid-19 battle: Restrictions on drug export may be lifted

Covid-19 battle: Restrictions on drug export may be lifted

Out of 13 drugs whose exports were restricted, the government is likely to lift the ban on five including paracetamol, tinidazole, metronidazole, ornidazole, and azithromycin, people in the know of the matter said.

Intas to provide 2 million hydroxychloroquine tablets for WHO study on COVID-19

Intas to provide 2 million hydroxychloroquine tablets for WHO study on COVID-19

Intas informed that it is collaborating on the WHO-endorsed study using hydroxychloroquine, a drug that may have an effect in preventing and/or reducing symptoms of COVID-19. The global COPCOV (chloroquine / hydroxychloroquine prevention of COVID-19 in the healthcare setting; a randomised, placebo-controlled prophylaxis).

COVID-19: Firms shortlisted for rapid antibody testing kits

COVID-19: Firms shortlisted for rapid antibody testing kits

Singapore-based Sensing Self Ltd and China’s Wondfo are the only companies that have cleared the National Institute of Virology (NIV)’s validation for rapid antibody test kit that can help in the fight against Covid-19.

Saarc requests India to lift export ban on drugs

Saarc requests India to lift export ban on drugs

Hydroxychloroquine received global attention recently after US President Donald Trump made claims that the drug was effective on Covid-19 patients. India is the largest exporter of hydroxychloroquine in the world, and companies that ET spoke to also confirmed they had received requests to airlift the drug from India.

GeM creates separate page for medical equipments to help govt fight Covid-19

GeM creates separate page for medical equipments to help govt fight Covid-19

Public procurement portal GeM has created a dedicated page on its platform for medical and protective equipment like thermal scanners, biohazard bags and disinfectants to help the government fight Covid-19 pandemic.

Load More...

Other useful Links

Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service